drugset / Trial / NCT03531229
Single Ascending Dose Study of Lu AF76432 in Healthy Young Men
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to investigate safety, tolerability and pharmacokinetics of the drug Lu AF76432 given as single oral ascending doses to healthy young men
Timeline
- Start
- 2018-04-17
- Primary completion
- 2019-02-22
- Completion
- 2019-02-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF76432 | Unknown | 3.5 mg | Oral |
Indications
No indication recorded.